Viventia Biotech Inc.
Records under this name other than patents Viventia Biotech Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,946,390 | Novel Cancer-Associated Antigen Formerly held In force · Low confidence | In force | Low confidence | |
| US 7,956,162 | Cancer-associated antigen Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,084,576 | Cancer associated glucose transporter 8 variant Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,697,075 | Cancer specific antibody and cell surface proteins Formerly held Term ended Term ended Dec 21, 2025 · USPTO record | Term ended | Term ended Dec 21, 2025 | USPTO record |
| US 8,716,234 | Cytotoxins Comprising Modified Bouganin Toxin for the Treatment of Cancer Held by another company Term ended Term ended Dec 15, 2025 · High confidence | Term ended | Term ended Dec 15, 2025 | High confidence |
| US 8,545,840 | Methods for treating cancer using an immunotoxin Formerly held Term ended Term ended Jun 24, 2025 · USPTO record | Term ended | Term ended Jun 24, 2025 | USPTO record |
| US 7,339,031 | Modified Bouganin Proteins, Cytotoxins and Methods and Uses Thereof Formerly held Term ended Term ended Jun 23, 2025 · High confidence | Term ended | Term ended Jun 23, 2025 | High confidence |
| US 8,969,540 | Tumor Specific Antibody Formerly held Term ended Term ended Jun 10, 2025 · Medium confidence | Term ended | Term ended Jun 10, 2025 | Medium confidence |
| US 7,750,136 | Modified Bouganin Proteins, Cytotoxins and Methods and Uses Thereof Formerly held Term ended Term ended May 8, 2025 · High confidence | Term ended | Term ended May 8, 2025 | High confidence |
| US 8,389,286 | Cancer-associated antigen Formerly held Lapsed on the fee record Ended Mar 5, 2025 · USPTO record | Lapsed on the fee record | Ended Mar 5, 2025 | USPTO record |